| Her, Sung-ho |
ALMIGHTY, NCT06186037: Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention |
|
|
| Recruiting | 4 | 6356 | RoW | Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg, Mono drug group of Rosuvastatin 20 mg | Saint Vincent's Hospital, Korea | Coronary Artery Disease, Dyslipidemias, Primary Prevention | 02/29 | 02/29 | | |
| Active, not recruiting | 4 | 2018 | RoW | Tailored antithrombotic strategy, Conventional antithrombotic strategy | Duk-Woo Park, MD, CardioVascular Research Foundation, Korea | Coronary Stenoses | 01/25 | 01/25 | | |
PROTECT-HBR, NCT04416581: Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy |
|
|
| Recruiting | 4 | 3100 | RoW | PPI, P-CAB 50 | Duk-Woo Park, MD | Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Myocardial Infarction | 09/26 | 12/27 | | |
NCT05758896: Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI |
|
|
| Recruiting | 2 | 280 | US, RoW | Isuzinaxib (APX-115), Isuzinaxib Hydrochloride, Placebo | Aptabio Therapeutics, Inc. | Contrast Induced Acute Kidney Injury | 09/24 | 12/24 | | |
| Recruiting | N/A | 1000 | RoW | BIOFREEDOM™ FAMILY stent | Seung-Jung Park, CardioVascular Research Foundation, Korea | Coronary Stenosis | 12/24 | 12/29 | | |
NCT05807841: Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI) |
|
|
| Recruiting | N/A | 3000 | RoW | percutaneous coronary intervention | Asan Medical Center, Boston Scientific Corporation | Coronary Artery Disease | 06/25 | 06/25 | | |
| Recruiting | N/A | 20000 | RoW | | Seung-Jung Park, CardioVascular Research Foundation, Korea, Abbott Medical Devices | Coronary Artery Disease | 04/37 | 04/37 | | |
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD |
|
|
| Recruiting | N/A | 2400 | RoW | Percutaneous Coronary Intervention | Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd | Coronary Disease | 12/26 | 07/30 | | |
STRIKE-CTO, NCT03667196: Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions |
|
|
| Recruiting | N/A | 4000 | RoW | antegrade and retrograde approach | Seung-Whan Lee, M.D., Ph.D., Abbott Medical Devices, Biotronik SE & Co. KG, Medtronic, Dio Medical | Chronic Total Occlusion of Coronary Artery | 12/27 | 12/27 | | |
PROVISIONDEB, NCT06002932: Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. |
|
|
| Recruiting | N/A | 750 | RoW | Procedure: planed 2-stent strategy, Procedure: provisional 1-stent plus DEB strategy | Saint Vincent's Hospital, Korea | Coronary Artery Disease, Ischemic Heart Disease | 07/28 | 12/28 | | |
